U.S. Senate Hearing: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process, Washington, District of Columbia, USA - 02 Jun 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S.,.